Red Light Holland Engages Akwasi Owusu-Bempah, Respected Academic, Author and Expert in Drug Law Reform and Drug Equity, as Advisory Board Advisor
Toronto, Ontario–(Newsfile Corp. – May 11, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based company engaged in the production, growth and sale of a premium brand range of magic truffles on the legal and recreational market in the Netherlands is pleased to announce that it has engaged Akwasi Owusu-Bempah to serve as an advisor to its advisory board.
Akwasi Owusu-Bempah (Ph.D.) is a respected Canadian scholar and drug law reform expert. He brings extensive experience working in the public and private sectors in Canada and abroad.
Akwasi’s scholarly work has examined the uneven nature of drug law enforcement in North America. He has worked with major media outlets to advance public dialogue about the perils of the war on drugs. As a changemaker, Akwasi has lobbied federal governments to overhaul their drug laws and, through his nonprofit work, has collaborated with some of the world’s largest cannabis companies to advance their corporate responsibility mandates. He recently served as a member of Health Canada’s Expert Working Group on Substance Use and has contributed to ongoing decriminalization efforts across the country.
“We are delighted to have Akwasi join the Red Light Advisory Board,” said Todd Shapiro, CEO and Director of Red Light Holland. “When we connected, I immediately knew he would be a perfect fit. Akwasi and Red Light are fully aligned with our beliefs that psilocybin should be accessible in an affordable and equitable way through education, information and responsible use. Akwasi is another great asset to the Red Light team and we are grateful as we believe that his experience, knowledge and past lobbying efforts as well as his educational articles will help open our eyes. and the ears of health regulators around the world.”
“I’m thrilled to be working with Red Light Holland and their efforts to bring psilocybin from the underground to the mainstream,” added Akwasi Owusu-Bempah. “Todd and his team have shown great leadership in the field of psychedelics and I look forward to contributing to the social purpose and advocacy strategy of the company as Red Light continues to grow and grow. grow. I’m proud to lend my expertise and knowledge to help Red Light’s mission.”
In consideration for his services as an advisor, and subject to all applicable laws (including the rules and policies of the Canadian Securities Exchange) (the “Applicable Laws”), the Company granted Mr. Owusu- Bempah 300,000 incentive stock options (the “Options” and each individually, the “Option”). Each option will entitle its holder to acquire one common share in the capital of the Company for a period of three years from the date of issue, but may only be exercised one-half at a time after 1 and 2 years respectively, at an exercise price of $0.09 CND Options are subject to applicable laws and the terms of the Company’s stock option plan.
Investor Platform Update
The company is also pleased to announce that it has released a new investor platform – the Red Light Triangle Approach – on its website. www.redlight.cooffering an in-depth look at the Society’s vision and its triangular approach to achieving that vision.
About Red Light Holland Corp.
The Company is an Ontario-based company positioned to engage in the generation, growth and sale (through existing Smart Shop operators and an advanced e-commerce platform) of a brand premium quality magic truffles on the legal and recreational market in the Netherlands, to the highest standards, in compliance with all applicable laws.
For more information :
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities laws. Such forward-looking information and forward-looking statements are not representative of historical facts or information or of the current condition, but rather represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside the control of the Company. Often, but not always, forward-looking statements and information can be identified by the use of words such as “anticipates”, “expects” or “does not expect”, “is expected”, “estimates”. , “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or states that certain actions, events or results “may”, “could”, “would”, “could” or “will” occur, occur or be realized. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: Todd Shapiro’s statement regarding the Akwasi opening the eyes and ears of healthcare regulators around the world; and Akwasi’s statement regarding the continued expansion and growth of Red Light.
The forward-looking information contained in this press release is based on certain assumptions and expected future events, namely: continued approval of the Company’s business by relevant governmental and/or regulatory authorities; the continued growth of the Company; the company adheres to its planned schedule and process for growth, sales, production and marketing; the Company’s products being safe and providing the expected benefits; continued demand for the Company’s products; the ability of Akwasi and Red Light to continue to work together; and Akwasi’s ability to impact healthcare regulators around the world.
The risks, uncertainties and other factors involved in forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, expectations regarding future growth and expansion of business operations; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in financial and stock markets; infectious disease risks, including the impacts of the COVID-19 pandemic; legal and regulatory risks inherent in the psychedelics industry, including the global regulatory landscape and enforcement of laws related to psychedelics; political risks and risks related to regulatory developments; risks related to anti-money laundering laws; compliance with extensive governmental regulations and interpretation of various laws, regulations and policies; public opinion and industry perception of psychedelics; and other risks contained in the Company’s public documents filed with the Canadian securities authorities and available under the Company’s profile on SEDAR at www.sedar.com.
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurances or warranties can be assured that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements contained or referred to herein. , except in accordance with applicable securities laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/123580